PDGF-D-PDGFRβ signaling enhances IL-15-mediated human natural killer cell survival.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35027451.
- Also identified by DOI 10.1073/pnas.2114134119 and PMC identifier 8784126.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The axis of platelet-derived growth factor (PDGF) and PDGF receptor-beta (PDGFRβ) plays prominent roles in cell growth and motility. In addition, PDGF-D enhances human natural killer (NK) cell effector functions when binding to the NKp44 receptor. Here, we report an additional but previously unknown role of PDGF-D, whereby it mediates interleukin-15 (IL-15)-induced human NK cell survival but not effector functions via its binding to PDGFRβ but independent of its binding to NKp44. Resting NK cells express no PDGFRβ and only a low level of PDGF-D, but both are significantly up-regulated by IL-15, via the nuclear factor κB signaling pathway, to promote cell survival in an autocrine manner. Both ectopic and IL-15-induced expression of PDGFRβ improves NK cell survival in response to treatment with PDGF-D. Our results suggest that the PDGF-D-PDGFRβ signaling pathway is a mechanism by which IL-15 selectively regulates the survival of human NK cells without modulating their effector functions.
Medical subject headings
- Interleukin-15
- Killer Cells, Natural
- Platelet-Derived Growth Factor
- Receptor, Platelet-Derived Growth Factor beta
- Signal Transduction